Potential therapeutic applications of autophagy

Nature Reviews Drug Discovery

Volumn 6, Issue 4, 2007, Pages 304-312

  Rubinsztein, David C ^a   Gestwicki, Jason E ^b   Murphy, Leon O ^c   Klionsky, Daniel J ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; BAFILOMYCIN A1; CARBAMAZEPINE; CHLOROQUINE; HYDROXYCHLOROQUINE; LITHIUM SALT; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RAPAMYCIN; TAMOXIFEN; TAU PROTEIN; VALPROIC ACID; WORTMANNIN;

AUTOPHAGY; CANCER; CELL DEATH; CELL PROTECTION; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG TARGETING; HUMAN; METABOLIC DISORDER; METABOLIC REGULATION; MOLECULAR DYNAMICS; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; PROTEINOPATHY; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; AUTOPHAGY; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; PROTEIN KINASES; SIROLIMUS;

EID: 33947719279     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd2272     Document Type: Review

References (92)

1. Tallóczy, Z., Virgin, H. W. IV & Levine, B. PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2, 24-29 (2006).
2. Paludan, C. et al. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307, 593-596 (2005).
3. Rubinsztein, D. C. et al. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy 1, 11-22 (2005).
4. Botti, J., Djavaheri-Mergny, M., Pilatte, Y. & Codogno, P. Autophagy signaling and the cogwheels of cancer. Autophagy 2, 67-73 (2006).
5. Jin, S. Autophagy, mitochondrial quality control, and oncogenesis. Autophagy 2, 80-84 (2006).
6. Kondo, Y. & Kondo, S. Autophagy and cancer therapy. Autophogy 2, 85-90 (2006).
7. Levine, B. Unraveling the role of autophagy in cancer. Autophagy 2, 65-66 (2006).
8. Belanger, M., Rodrigues, P. H., Dunn, W. A. Jr. & Progulske-Fox, A. Autophagy: A highway for Porphyromonas gingivalis in endothelial cells. Autophagy 2, 165-170 (2006).
9. Birmingham, C. L. & Brumell, J. H. Autophagy recognizes intracellular Salmonella enterica serovar Typhimurium in damaged vacuoles. Autophagy 2, 156-158 (2006).
10. Colombo, M. I., Gutierrez, M. G. & Romano, P. S. The two faces of autophagy: Coxiella and Mycobacterium. Autophagy 2, 162-164 (2006).
11. Dubuisson, J. F. & Swanson, M. S. Mouse infection by Legionella, a model to analyze autophagy. Autophagy 2, 179-182 (2006).
12. Ogawa, M. & Sasakawa, C. Shigella and autophagy. Autophagy 2, 171-174 (2006).
13. Vergne, I. et al. Autophagy in immune defense against Mycobacterium tuberculosis. Autophagy 2, 175-178 (2006).
14. Webster, P. Cytoplasmic bacteria and the autophagic pathway. Autophagy 2, 159-161 (2006).
15. Yoshimori, T. Autophagy vs. group A Streptococcus. Autophagy 2, 154-155 (2006).
16. Klionsky, D. J. Autophagy (Landes Bioscience, Georgetown, 2004).
17. Wang, C.-W. & Klionsky, D. J. The molecular mechanism of autophagy. Mol. Med. 9, 65-76 (2003).
18. Massey, A. C., Zhang, C. & Cuervo, A. M. Chaperone-mediated autophagy in aging and disease. Curr. Top. Dev. Biol. 73, 205-235 (2006).
19. Yorimitsu, T. & Klionsky, D. J. Autophagy: Molecular machinery for self-eating. Cell Death Differ. 12, 1542-1552 (2005).
20. Klionsky, D. J. et al. A unified nomenclature for yeast autophagy-related genes. Dev. Cell 5, 539-545 (2003).
21. Reggiori, F. & Klionsky, D. J. Autophagy in the eukaryotic cell. Eukaryot. Cell 1, 11-21 (2002).
22. Ohsumi, Y. & Mizushima, N. Two ubiquitin-like conjugation systems essential for autophagy. Semin. Cell Dev. Biol. 15, 231-236 (2004).
23. Nair, U. & Klionsky D. J. Molecular mechanisms and regulation of specific and nonspecific autophagy pathways in yeast. J. Biol. Chem. 280, 41785-41788 (2005).
24. Kihara, A., Kabeya, Y., Ohsumi, Y. & Yoshimori, T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2, 330-335 (2001).
25. Petiot, A., Ogier-Denis, E., Blommaart, E. F., Meijer, A. J. & Codogno, P. Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 275, 992-998 (2000).
26. Kihara, A., Noda, T., Ishihara, N. & Ohsumi, Y. Two distinct Vps34 phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y sorting in Saccharomyces cerevisiae. J. Cell Biol. 152, 519-530 (2001).
27. Liang, X. H. et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402, 672-676 (1999).
28. Ou, X. et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112, 1809-1820 (2003).
29. Young, A. R. J. et al. Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes. J. Cell Sci. 119, 3888-3900 (2006).
30. Noda, T. et al. Apg9p/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways. J. Cell Biol. 148, 465-480 (2000).
31. Blommaart, E. F., Luiken, J. J., Blommaart, P. J., van Woerkom, G. M. & Meijer. A. J. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270, 2320-2326 (1995).
32. Kamada, Y. et al. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J. Cell Biol. 150, 1507-1513 (2000).
33. Klionsky, D. J., Meijer, A. J., Codogno, P., Neufeld, T. P. & Scott, R. C. Autophagy and p70S6 kinase. Autophagy 1, 59-61 (2005).
34. Noda, T. & Ohsumi, Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273, 3963-3966 (1998).
35. Bjornsti, M. A. & Houghton, P. J. The TOR pathway: A target for cancer therapy. Nature Rev. Cancer 4, 335-348 (2004).
36. Galanis, E. et al. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A North Central Cancer Treatment Group Study. J. Clin. Oncol. 23, 5294-5304 (2005).
37. Lee, V. W. & Chapman, J. R. Sirolimus: Its role in nephrology. Nephrology (Carlton) 10, 606-614 (2005).
38. Frias, M. A. et al. mSin 1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr. Biol. 16, 1865-1870 (2006).
39. Sarbassov, D. D., Guertin, D. A., Ali. S. M. & Sabatini, D. M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101 (2005).
40. Sarbassov, D. D. et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 122, 159-168 (2006).
41. Sabatini, D. M. mTOR and cancer: Insights into a complex relationship. Nature Rev. Cancer 6, 729-34 (2006).
42. Sarkar S. et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 170, 1101-1111 (2005).
43. Berridge, M. J. Unlocking the secrets of cell signaling. Annu. Rev. Physiol. 67, 1-21 (2005).
44. Menzies, F. M., Ravikumar, B. & Rubinsztein, D. C. Protective roles for induction of autophagy in multiple proteinopathies. Autophagy 2, 224-225 (2006).
45. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805-810 (2004).
46. Sanchez, I., Mahlke, C. & Yuan, J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421, 373-379 (2003).
47. Ravikumar, B., Duden, R. & Rubinsztein, D. C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11, 1107-1117 (2002).
48. Webb, J. L., Ravikumar B., Atkins, J., Skepper, J. N. & Rubinsztein, D. C. α-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009-25013 (2003).
49. Iwata, A. et al. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc. Natl Acad. Sci. USA 102, 13135-13140 (2005).
50. Qin, Z. H. et al. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum. Mol. Genet. 12, 3231-3244 (2003).
51. Shibata, M. et al. Regulation of intracellular accumulation of mutant huntingtin by Beclin 1. J. Biol. Chem. 281, 14474-14485 (2006).
52. Ravikumar, B. et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nature Genet. 36, 585-595 (2004).
53. Berger, Z. et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 15, 433-442 (2006).
54. Kabuta, T., Suzuki, Y. & Wada, K. Degradation of amyotrophic lateral sclerosis-linked mutant Cu, Zn-superoxide dismutase proteins by macroautophagy and the proteasome. J. Biol. Chem. 281, 30524-30533 (2006).
55. Fortun, J., Dunn, W. A., Jr., Joy, S., Li. J. & Notterpek, L. Emerging role for autophagy in the removal of aggresomes in Schwann cells. J. Neurosci. 23, 10672-10680 (2003).
56. Hara, T. et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889 (2006).
57. Komatsu, M. et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884 (2006).
58. Yamamoto, A., Lucas, J. J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57-66 (2000).
59. Ravikumar, B., Berger, Z., Vacher, C., O'Kane, C. J. & Rubinsztein, D. C. Rapamycin pre-treatment protects against apoptosis. Hum. Mol. Genet. 15, 1209-1216 (2006).
60. Kessel, D. & Reiners, J. J. Jr. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1. Cancer Lett. 18 Oct 2006 (doi:10.1016/ j.canlet.2006.09.009).
61. Saeki, K. et al. Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cells. Cell Death Differ. 7, 1263-1269 (2000).
62. Verhoef, L. G., Lindsten, K., Masucci, M. G. & Dantuma, N. P. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Hum. Mol. Genet. 11, 2689-2700 (2002).
63. Gutierrez, M. G. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753-766 (2004).
64. Nakagawa, J. et al. Autophagy defends cells against invading group A Streptococcus. Science 306, 1037-1040 (2004).
65. Kirkegaard, K., Taylor, M. P. & Jackson. W. T. Cellular autophagy: surrender, avoidance and subversion by microorganisms. Nature Rev. Microbiol. 2, 301-314 (2004).
66. Crighton, D. et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126, 121-134 (2006).
67. Jin, S. p53, autophagy and tumor suppression. Autophagy 1, 171-173 (2005).
68. Hippert, M. M., O'Toole P, S. & Thorburn, A. Autophagy in cancer: Good, bad, or both? Cancer Res. 66, 9349-9351 (2006).
69. Shintani, T. & Klionsky, D. J. Autophagy in health and disease: A double-edged sword. Science 306, 990-995 (2004).
70. Wienecke, R. et al. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. Am. J. Kidney Dis. 48, e27-e29 (2006).
71. Furuya, N., Liang, X. H. & Levine, B. in Autophagy (ed. Klionsky, D. J.) 241-255 (Landes Bioscience, Georgetown, 2004).
72. Amaravadi, R. K. et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. (2007).
73. Cantley, L. C. & Neel, B. G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/ AKT pathway. Proc. Natl Acad. Sci. USA 96, 4240-4245 (1999).
74. Liu, Z. & Roberts, T. M. Human tumor mutants in the p110α subunit of P13K. Cell Cycle 5, 675-677 (2006).
75. Vanhaesebroeck, B., Ali, K., Bilancio, A., Geering, B. & Foukas, L. C. Signalling by P13K isoforms: Insights from gene-targeted mice. Trends Biochem. Sci. 30, 194-204 (2005).
76. Ward, S. G. & Finan, P. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents. Curr. Opin. Pharmacol. 3, 426-434 (2003).
77. Degenhardt, K. et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64 (2006).
78. Lum, J. J. et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237-248 (2005).
79. Knight, Z. A. et al. A pharmacological map of the P13-K family defines a role for p110α in insulin signaling. Cell 125, 733-747 (2006).
80. Fan, Q. W. et al. A dual P13 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 9, 341-349 (2006).
81. Hay, N. & Sonenberg, N. Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945 (2004).
82. Yamamoto, A. et al. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23, 33-42 (1998).
83. Fass, E., Shvets, E., Degani, I., Hirschberg, K. & Elazar, Z. Microtubules support production of starvation-induced autophagosomes but not their targeting and fusion with lysosomes. J. Biol. Chem. 281, 36303-36316 (2006).
84. Boya, P. et al. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25, 1025-1040 (2005).
85. Oltersdorf, T. et al. An inhibitor of Bcl-2 family protiens induces regression of solid tumours. Nature 435, 677-681 (2005).
86. Leung-Toung, R. et al. Thiol proteases: Inhibitors and potential therapeutic targets. Curr. Med. Chem. 13, 547-581 (2006).
87. Kumanomidou, T. et al. The crystal structure of human Atg4b, a processing and de-conjugating enzyme for autophagosome-forming modifiers. J. Mol. Biol. 355, 612-618 (2006).
88. Knight, Z. A. & Shokat, K. M. Features of selective kinase inhibitors. Chem. Biol. 12, 621-637 (2005).
89. Levitzki, A. & Gazit, A. Tyrosine kinase inhibition: An approach to drug development. Science 267, 1782-1788 (1995).
90. Berg, T. Modulation of protein-protein interactions with small organic molecules. Angew. Chem. Int. Ed. Engl. 42, 2462-2481 (2003).
91. Gestwicki, J. E., Crabtree, G. R. & Graef, I. A. Harnessing chaperones to generate small-molecule inhibitors of amyloid β aggregation. Science 306, 865-869 (2004).
92. Toogood, P. L. Inhibition of protein-protein association by small molecules: Approaches and progress. J. Med. Chem. 45, 1543-1558 (2002).